Faculty

Jian L. Campian, M.D., Ph.D.

Clinical Studies

Open

A Phase 2, Single-Arm, Multicenter, Open-Label Study Of Zanzalintinib In Participants With Recurrent Or Progressive Meningioma Scottsdale/Phoenix, AZ Jacksonville, FL Rochester, MN The objective of the study is to evaluate efficacy and safety of zanzalintinib in participants with recurrent or progressive meningioma refractory to standard therapies.

Closed for Enrollment

MC210706 Efficacy And Safety Study Of Neoadjuvant Efineptakin Alfa (NT-I7) Plus Pembrolizumab In Recurrent Glioblastoma Rochester, MN
The purpose of this study is to determine the response rate to the combination of pembrolizumab and NT-I7 in patients with recurrent glioblastoma.

.

.